TOP STORIES

• BUSINESS Bayer Japan Chief “Disappointed” at PMP Removal for Xarelto, Shows Eagerness for Add’l Indications
  April 27, 2018

• REGULATORY Imfinzi Sails through MHLW Panel, Now in Line for Stage III NSCLC Nod
  April 26, 2018

• ORGANIZATION PhRMA/EFPIA Say Humira, Jevtana, Xarelto Lost Eligibility under New PMP, Innovation Not Appropriately Defined
  April 26, 2018

• BUSINESS Takeda, Shire Reach Preliminary Deal, Extend Takeover Deadline to May 8
  April 25, 2018

• BUSINESS Takeda Makes Fifth Pitch for Shire Buyout as Deadline Looms
  April 25, 2018

• BUSINESS Novartis Seeks Japan Approval for Kymriah, Will Outcome-Based Model Be Put in Place?
  April 24, 2018

• ACADEMIA Clinical Trials for Mitochondrial Disease Heating Up with AMED’s Support; Filing for First Hyperlactacidemia Drug Expected in 2020
  April 23, 2018

• BUSINESS Takeda Sweetens Bid for Shire, Ups Cash Component
  April 23, 2018

• BUSINESS Takeda in Talks with Shire after 3 Buyout Proposals Rejected
  April 20, 2018

• TRENDS Industry Group Anticipates New Demand for Contract Reps after Current Phase of Downsizing by Drug Makers
  April 20, 2018

• BUSINESS Tecentriq Now in PD-1/L1 NSCLC Showdown, Lynparza Also Hits Japan Market
  April 19, 2018

• ACADEMIA Physicians Association Initiates Large-Scale Study to Directly Compare DPP-4 Inhibitors to SGLT2 Inhibitors, Determine “Optimal Patients” for Each
  April 19, 2018

• BUSINESS Another Huge Seller Re-Pricing Won’t Hit Opdivo Unless 195 Billion Yen Sales Reached: Ono Chief
  April 18, 2018

• BUSINESS Sumitomo Dainippon Reorganizes Drug Discovery Research System; Accelerating Decision-Making: Pres.
  April 18, 2018

• REGULATORY Pharma Leaders Air Grievances on Pricing Reform Package at New MHLW Confab
  April 17, 2018

• BUSINESS Takeda CEO Eager to Lure More Partners to Shonan iPark, Says Diversity Is Source of Creativity
  April 16, 2018

• BUSINESS Shonan Health Innovation Park Marks Grand Opening: Takeda
  April 16, 2018

• ORGANIZATION PhRMA Chief Warns of Serious Implications for Japan Market after 2018 Pricing Reform
  April 13, 2018

• REGULATORY Chuikyo Payer Rep Questions New Premium System for Cost-Based Pricing Method
  April 12, 2018

• REGULATORY MOF Calls for Using CEA to Make Reimbursement Decisions for Pricy Drugs
  April 12, 2018

ページ

• « 先頭
• ‹ Prev
• …
• 146
• 147
• 148
• 149
• 150
• 151
• 152
• 153
• 154
• …
• Next ›
• 最終 »